Estimates of potential TAVI candidates highlight a significant upcoming burden on healthcare resources, especially if indications expand to low-risk patients.
Currently, approximately 180 000 patients can be considered potential TAVI candidates in the European Union and in Northern-America annually. This number might increase up to 270 000 if indications for TAVI expand to low-risk patients. These findings have major implications for health care resource planning in the 29 individual countries.
Durko et al. (Mon,) studied this question.
Synapse has enriched one closely related paper. Consider it for comparative context: